?>
| Plan Name | AEGLEA BIOTHERAPEUTICS, INC. 401(K) PLAN |
| Plan identification number | 001 |
| 401k Plan Type | Defined Contribution Pension |
| Plan Features/Benefits |
|
| Company Name: | AEGLEA BIOTHERAPEUTICS, INC. |
| Employer identification number (EIN): | 464312787 |
| NAIC Classification: | 622000 |
| NAIC Description: | Hospitals |
Additional information about AEGLEA BIOTHERAPEUTICS, INC.
| Jurisdiction of Incorporation: | Texas Secretary of State |
| Incorporation Date: | 2013-12-20 |
| Company Identification Number: | 0801902595 |
| Legal Registered Office Address: |
1606 HEADWAY CIR STE 9025 AUSTIN United States of America (USA) 78754 |
More information about AEGLEA BIOTHERAPEUTICS, INC.
| Plan id# | Filing Submission Date | Name of Administrator | Date Administrator Signed | Name of Company Sponsor | Date Sponsor Signed |
|---|---|---|---|---|---|
| 001 | 2024-01-01 | JONATHAN CAMPBELL | |||
| 001 | 2023-01-01 | ||||
| 001 | 2023-01-01 | JONATHAN CAMPBELL | |||
| 001 | 2022-01-01 | ||||
| 001 | 2022-01-01 | JONATHAN CAMPBELL | |||
| 001 | 2021-01-01 | ||||
| 001 | 2021-01-01 | EUGENE SACKETT | |||
| 001 | 2020-01-01 | ||||
| 001 | 2019-01-01 | ||||
| 001 | 2018-01-01 | STEVEN WEBER | 2019-06-18 | ||
| 001 | 2017-01-01 | STEVEN WEBER | 2018-07-20 | ||
| 001 | 2016-09-16 | STEVEN WEBER | 2017-09-20 |
| Measure | Date | Value |
|---|---|---|
| 2023: AEGLEA BIOTHERAPEUTICS, INC. 401(K) PLAN 2023 401k membership | ||
| Total participants, beginning-of-year | 2023-01-01 | 111 |
| Total number of active participants reported on line 7a of the Form 5500 | 2023-01-01 | 16 |
| Number of retired or separated participants receiving benefits | 2023-01-01 | 0 |
| Number of other retired or separated participants entitled to future benefits | 2023-01-01 | 64 |
| Total of all active and inactive participants | 2023-01-01 | 80 |
| Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2023-01-01 | 0 |
| Total participants | 2023-01-01 | 80 |
| Number of participants with account balances | 2023-01-01 | 76 |
| Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2023-01-01 | 0 |
| 2022: AEGLEA BIOTHERAPEUTICS, INC. 401(K) PLAN 2022 401k membership | ||
| Total participants, beginning-of-year | 2022-01-01 | 107 |
| Total number of active participants reported on line 7a of the Form 5500 | 2022-01-01 | 61 |
| Number of retired or separated participants receiving benefits | 2022-01-01 | 0 |
| Number of other retired or separated participants entitled to future benefits | 2022-01-01 | 50 |
| Total of all active and inactive participants | 2022-01-01 | 111 |
| Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2022-01-01 | 0 |
| Total participants | 2022-01-01 | 111 |
| Number of participants with account balances | 2022-01-01 | 105 |
| Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2022-01-01 | 0 |
| 2021: AEGLEA BIOTHERAPEUTICS, INC. 401(K) PLAN 2021 401k membership | ||
| Total participants, beginning-of-year | 2021-01-01 | 90 |
| Total number of active participants reported on line 7a of the Form 5500 | 2021-01-01 | 81 |
| Number of retired or separated participants receiving benefits | 2021-01-01 | 0 |
| Number of other retired or separated participants entitled to future benefits | 2021-01-01 | 26 |
| Total of all active and inactive participants | 2021-01-01 | 107 |
| Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2021-01-01 | 0 |
| Total participants | 2021-01-01 | 107 |
| Number of participants with account balances | 2021-01-01 | 98 |
| Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2021-01-01 | 0 |
| 2020: AEGLEA BIOTHERAPEUTICS, INC. 401(K) PLAN 2020 401k membership | ||
| Total participants, beginning-of-year | 2020-01-01 | 77 |
| Total number of active participants reported on line 7a of the Form 5500 | 2020-01-01 | 75 |
| Number of retired or separated participants receiving benefits | 2020-01-01 | 0 |
| Number of other retired or separated participants entitled to future benefits | 2020-01-01 | 15 |
| Total of all active and inactive participants | 2020-01-01 | 90 |
| Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2020-01-01 | 0 |
| Total participants | 2020-01-01 | 90 |
| Number of participants with account balances | 2020-01-01 | 81 |
| Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2020-01-01 | 0 |
| 2019: AEGLEA BIOTHERAPEUTICS, INC. 401(K) PLAN 2019 401k membership | ||
| Total participants, beginning-of-year | 2019-01-01 | 45 |
| Total number of active participants reported on line 7a of the Form 5500 | 2019-01-01 | 68 |
| Number of retired or separated participants receiving benefits | 2019-01-01 | 0 |
| Number of other retired or separated participants entitled to future benefits | 2019-01-01 | 9 |
| Total of all active and inactive participants | 2019-01-01 | 77 |
| Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2019-01-01 | 0 |
| Total participants | 2019-01-01 | 77 |
| Number of participants with account balances | 2019-01-01 | 65 |
| Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2019-01-01 | 0 |
| Measure | Date | Value |
|---|---|---|
| 2023 : AEGLEA BIOTHERAPEUTICS, INC. 401(K) PLAN 2023 401k financial data | ||
| Transfers to/from the plan | 2023-12-31 | $0 |
| Total plan liabilities at end of year | 2023-12-31 | $0 |
| Total plan liabilities at beginning of year | 2023-12-31 | $0 |
| Total income from all sources | 2023-12-31 | $1,725,680 |
| Expenses. Total of all expenses incurred | 2023-12-31 | $2,708,044 |
| Benefits paid (including direct rollovers) | 2023-12-31 | $2,703,477 |
| Total plan assets at end of year | 2023-12-31 | $4,064,299 |
| Total plan assets at beginning of year | 2023-12-31 | $5,046,663 |
| Value of fidelity bond covering the plan | 2023-12-31 | $500,000 |
| Assets. Value of tangible personal property | 2023-12-31 | $0 |
| Total contributions received or receivable from participants | 2023-12-31 | $583,570 |
| Assets. Value of loans (other than to participants) | 2023-12-31 | $0 |
| Expenses. Other expenses not covered elsewhere | 2023-12-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2023-12-31 | $108,831 |
| Other income received | 2023-12-31 | $729,656 |
| Noncash contributions received | 2023-12-31 | $0 |
| Net income (gross income less expenses) | 2023-12-31 | $-982,364 |
| Net plan assets at end of year (total assets less liabilities) | 2023-12-31 | $4,064,299 |
| Net plan assets at beginning of year (total assets less liabilities) | 2023-12-31 | $5,046,663 |
| Assets. Value of participant loans | 2023-12-31 | $16,700 |
| Assets. Value of assets in partnership/joint-venture interests | 2023-12-31 | $0 |
| Assets. Value of real-estate (other than employer real property) | 2023-12-31 | $0 |
| Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2023-12-31 | $0 |
| Assets. Value of employer securities | 2023-12-31 | $0 |
| Assets. Value of employer real property | 2023-12-31 | $0 |
| Total contributions received or receivable from employer(s) | 2023-12-31 | $303,623 |
| Value of certain deemed distributions of participant loans | 2023-12-31 | $0 |
| Value of corrective distributions | 2023-12-31 | $2,711 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2023-12-31 | $1,856 |
| 2022 : AEGLEA BIOTHERAPEUTICS, INC. 401(K) PLAN 2022 401k financial data | ||
| Transfers to/from the plan | 2022-12-31 | $0 |
| Total plan liabilities at end of year | 2022-12-31 | $0 |
| Total plan liabilities at beginning of year | 2022-12-31 | $0 |
| Total income from all sources | 2022-12-31 | $930,205 |
| Expenses. Total of all expenses incurred | 2022-12-31 | $898,734 |
| Benefits paid (including direct rollovers) | 2022-12-31 | $897,978 |
| Total plan assets at end of year | 2022-12-31 | $5,046,663 |
| Total plan assets at beginning of year | 2022-12-31 | $5,015,192 |
| Value of fidelity bond covering the plan | 2022-12-31 | $500,000 |
| Assets. Value of tangible personal property | 2022-12-31 | $0 |
| Total contributions received or receivable from participants | 2022-12-31 | $1,222,581 |
| Assets. Value of loans (other than to participants) | 2022-12-31 | $0 |
| Expenses. Other expenses not covered elsewhere | 2022-12-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2022-12-31 | $65,786 |
| Other income received | 2022-12-31 | $-965,902 |
| Noncash contributions received | 2022-12-31 | $0 |
| Net income (gross income less expenses) | 2022-12-31 | $31,471 |
| Net plan assets at end of year (total assets less liabilities) | 2022-12-31 | $5,046,663 |
| Net plan assets at beginning of year (total assets less liabilities) | 2022-12-31 | $5,015,192 |
| Assets. Value of participant loans | 2022-12-31 | $17,614 |
| Assets. Value of assets in partnership/joint-venture interests | 2022-12-31 | $0 |
| Assets. Value of real-estate (other than employer real property) | 2022-12-31 | $0 |
| Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2022-12-31 | $0 |
| Assets. Value of employer securities | 2022-12-31 | $0 |
| Assets. Value of employer real property | 2022-12-31 | $0 |
| Total contributions received or receivable from employer(s) | 2022-12-31 | $607,740 |
| Value of certain deemed distributions of participant loans | 2022-12-31 | $0 |
| Value of corrective distributions | 2022-12-31 | $0 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2022-12-31 | $756 |
| 2021 : AEGLEA BIOTHERAPEUTICS, INC. 401(K) PLAN 2021 401k financial data | ||
| Transfers to/from the plan | 2021-12-31 | $0 |
| Total plan liabilities at end of year | 2021-12-31 | $0 |
| Total plan liabilities at beginning of year | 2021-12-31 | $0 |
| Total income from all sources | 2021-12-31 | $2,120,824 |
| Expenses. Total of all expenses incurred | 2021-12-31 | $698,405 |
| Benefits paid (including direct rollovers) | 2021-12-31 | $697,974 |
| Total plan assets at end of year | 2021-12-31 | $5,015,192 |
| Total plan assets at beginning of year | 2021-12-31 | $3,592,773 |
| Value of fidelity bond covering the plan | 2021-12-31 | $300,859 |
| Total contributions received or receivable from participants | 2021-12-31 | $986,481 |
| Expenses. Other expenses not covered elsewhere | 2021-12-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2021-12-31 | $29,412 |
| Other income received | 2021-12-31 | $592,998 |
| Noncash contributions received | 2021-12-31 | $0 |
| Net income (gross income less expenses) | 2021-12-31 | $1,422,419 |
| Net plan assets at end of year (total assets less liabilities) | 2021-12-31 | $5,015,192 |
| Net plan assets at beginning of year (total assets less liabilities) | 2021-12-31 | $3,592,773 |
| Assets. Value of participant loans | 2021-12-31 | $8,407 |
| Total contributions received or receivable from employer(s) | 2021-12-31 | $511,933 |
| Value of certain deemed distributions of participant loans | 2021-12-31 | $0 |
| Value of corrective distributions | 2021-12-31 | $0 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2021-12-31 | $431 |
| 2020 : AEGLEA BIOTHERAPEUTICS, INC. 401(K) PLAN 2020 401k financial data | ||
| Transfers to/from the plan | 2020-12-31 | $0 |
| Total plan liabilities at end of year | 2020-12-31 | $0 |
| Total plan liabilities at beginning of year | 2020-12-31 | $0 |
| Total income from all sources | 2020-12-31 | $1,811,522 |
| Expenses. Total of all expenses incurred | 2020-12-31 | $407,270 |
| Benefits paid (including direct rollovers) | 2020-12-31 | $407,089 |
| Total plan assets at end of year | 2020-12-31 | $3,592,773 |
| Total plan assets at beginning of year | 2020-12-31 | $2,188,521 |
| Value of fidelity bond covering the plan | 2020-12-31 | $300,859 |
| Total contributions received or receivable from participants | 2020-12-31 | $836,205 |
| Expenses. Other expenses not covered elsewhere | 2020-12-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2020-12-31 | $20,628 |
| Other income received | 2020-12-31 | $505,555 |
| Noncash contributions received | 2020-12-31 | $0 |
| Net income (gross income less expenses) | 2020-12-31 | $1,404,252 |
| Net plan assets at end of year (total assets less liabilities) | 2020-12-31 | $3,592,773 |
| Net plan assets at beginning of year (total assets less liabilities) | 2020-12-31 | $2,188,521 |
| Assets. Value of participant loans | 2020-12-31 | $41,855 |
| Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2020-12-31 | $0 |
| Total contributions received or receivable from employer(s) | 2020-12-31 | $449,134 |
| Value of certain deemed distributions of participant loans | 2020-12-31 | $0 |
| Value of corrective distributions | 2020-12-31 | $0 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2020-12-31 | $181 |
| 2019 : AEGLEA BIOTHERAPEUTICS, INC. 401(K) PLAN 2019 401k financial data | ||
| Transfers to/from the plan | 2019-12-31 | $0 |
| Total plan liabilities at end of year | 2019-12-31 | $0 |
| Total plan liabilities at beginning of year | 2019-12-31 | $0 |
| Total income from all sources | 2019-12-31 | $1,216,084 |
| Expenses. Total of all expenses incurred | 2019-12-31 | $76,947 |
| Benefits paid (including direct rollovers) | 2019-12-31 | $75,941 |
| Total plan assets at end of year | 2019-12-31 | $2,188,521 |
| Total plan assets at beginning of year | 2019-12-31 | $1,049,384 |
| Value of fidelity bond covering the plan | 2019-12-31 | $130,000 |
| Total contributions received or receivable from participants | 2019-12-31 | $571,621 |
| Expenses. Other expenses not covered elsewhere | 2019-12-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2019-12-31 | $0 |
| Other income received | 2019-12-31 | $383,732 |
| Noncash contributions received | 2019-12-31 | $0 |
| Net income (gross income less expenses) | 2019-12-31 | $1,139,137 |
| Net plan assets at end of year (total assets less liabilities) | 2019-12-31 | $2,188,521 |
| Net plan assets at beginning of year (total assets less liabilities) | 2019-12-31 | $1,049,384 |
| Assets. Value of participant loans | 2019-12-31 | $34,572 |
| Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2019-12-31 | $0 |
| Total contributions received or receivable from employer(s) | 2019-12-31 | $260,731 |
| Value of certain deemed distributions of participant loans | 2019-12-31 | $0 |
| Value of corrective distributions | 2019-12-31 | $0 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2019-12-31 | $1,006 |
| 2023: AEGLEA BIOTHERAPEUTICS, INC. 401(K) PLAN 2023 form 5500 responses | ||
|---|---|---|
| 2023-01-01 | Type of plan entity | Single employer plan |
| 2023-01-01 | This submission is the final filing | No |
| 2023-01-01 | Plan is a collectively bargained plan | No |
| 2023-01-01 | Plan funding arrangement – Trust | Yes |
| 2023-01-01 | Plan benefit arrangement - Trust | Yes |
| 2022: AEGLEA BIOTHERAPEUTICS, INC. 401(K) PLAN 2022 form 5500 responses | ||
| 2022-01-01 | Type of plan entity | Single employer plan |
| 2022-01-01 | Submission has been amended | No |
| 2022-01-01 | This submission is the final filing | No |
| 2022-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2022-01-01 | Plan is a collectively bargained plan | No |
| 2022-01-01 | Plan funding arrangement – Trust | Yes |
| 2022-01-01 | Plan benefit arrangement - Trust | Yes |
| 2021: AEGLEA BIOTHERAPEUTICS, INC. 401(K) PLAN 2021 form 5500 responses | ||
| 2021-01-01 | Type of plan entity | Single employer plan |
| 2021-01-01 | This submission is the final filing | No |
| 2021-01-01 | Plan is a collectively bargained plan | No |
| 2021-01-01 | Plan funding arrangement – Trust | Yes |
| 2021-01-01 | Plan benefit arrangement - Trust | Yes |
| 2020: AEGLEA BIOTHERAPEUTICS, INC. 401(K) PLAN 2020 form 5500 responses | ||
| 2020-01-01 | Type of plan entity | Single employer plan |
| 2020-01-01 | Submission has been amended | No |
| 2020-01-01 | This submission is the final filing | No |
| 2020-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2020-01-01 | Plan is a collectively bargained plan | No |
| 2020-01-01 | Plan funding arrangement – Trust | Yes |
| 2020-01-01 | Plan benefit arrangement - Trust | Yes |
| 2019: AEGLEA BIOTHERAPEUTICS, INC. 401(K) PLAN 2019 form 5500 responses | ||
| 2019-01-01 | Type of plan entity | Single employer plan |
| 2019-01-01 | Submission has been amended | No |
| 2019-01-01 | This submission is the final filing | No |
| 2019-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2019-01-01 | Plan is a collectively bargained plan | No |
| 2019-01-01 | Plan funding arrangement – Trust | Yes |
| 2019-01-01 | Plan benefit arrangement - Trust | Yes |